Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01018329 · ClinicalTrials.gov registry record · NA
Magnetic Resonance Imaging in Evaluating Response to RadiationTherapy in Patients With High Grade Glioma
A NA study, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT01018329: Completed NA study, sponsored by Abramson Cancer Center at Penn Medicine.
NCT01018329 is a NA study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01018329, a NA study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
RATIONALE: Diagnostic procedures, such as magnetic resonance imaging, may help doctors predict a patient's response to treatment and help plan the best treatment. PURPOSE: This clinical trial is studying magnetic resonance imaging in response to radiation therapy in patients with high grade glioma.
Interventions
- PROCEDURE Magnetic Resonance Imaging
- PROCEDURE Magnetic Resonance Spectroscopic Imaging
- PROCEDURE Diffusion Tensor Imaging
- PROCEDURE Dynamic Contract-Enhanced magnetic resonance imaging
- PROCEDURE Diffusion-weighted magnetic resonance imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2009-07 |
| Est. Completion | 2012-12 |
| Phase | NA |
What the finished NCT01018329 record still lists
NCT01018329 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which Magnetic Resonance Imaging is the first listed.
NCT01018329 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01018329 about?
NCT01018329 is a clinical study titled "Magnetic Resonance Imaging in Evaluating Response to RadiationTherapy in Patients With High Grade Glioma". RATIONALE: Diagnostic procedures, such as magnetic resonance imaging, may help doctors predict a patient's response to treatment and help plan the best treatment. PURPOSE: This clinical trial is studying magnetic resonance imaging in response to radiation therapy in patients with high grade glioma.
What is the current status of trial NCT01018329?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2009-07. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01018329?
The interventions under investigation include: Magnetic Resonance Imaging (PROCEDURE), Magnetic Resonance Spectroscopic Imaging (PROCEDURE), Diffusion Tensor Imaging (PROCEDURE), Dynamic Contract-Enhanced magnetic resonance imaging (PROCEDURE), Diffusion-weighted magnetic resonance imaging (PROCEDURE).
Who is sponsoring clinical trial NCT01018329?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01018329's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia